ProCGlobal and endogenous thrombin potential during pregnancy

American Journal of Obstetrics and Gynecology

Volumn 203, Issue 5, 2010, Pages 463.e1-463.e6

  Hron, Gregor ^a   Kyrle, Paul A ^a   Kaider, Alexandra ^a   Philipp, Karl ^b   Pabinger, Ingrid ^a   Kollars, Marietta ^a   Eichinger, Sabine ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b DANUBE HOSPITAL   (Austria)

Author keywords

endogenous thrombin potential; low molecular weight heparin; pregnancy; ProCGlobal

Indexed keywords

DALTEPARIN; ENOXAPARIN; THROMBIN;

ADULT; ANTITHROMBIN DEFICIENCY; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TEST; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROCGLOBAL ASSAY; PROSPECTIVE STUDY; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; THROMBOPHILIA; THROMBOSIS PREVENTION; VENOUS BLOOD; VENOUS THROMBOEMBOLISM;

EID: 78149280309     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2010.05.034     Document Type: Article

References (19)

1. B. Brenner Hemostatic changes in pregnancy Thromb Res 114 2004 409 414
2. M. Franchini Hemostasis and pregnancy Thromb Haemost 95 2006 401 413
3. S. Eichinger, A. Weltermann, and K. Philipp Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden Thromb Haemost 82 1999 1232 1236
4. K. Abou-Nassar, M.J. Kovacs, and S.R. Kahn The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia: a randomized trial Thromb Haemost 98 2007 163 171
5. F. Cerneca, G. Ricci, R. Simeone, M. Malisano, S. Alberico, and S. Guaschino Coagulation and fibrinolysis changes in normal pregnancy: increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis Eur J Obstet Gynecol Reprod Biol 73 1997 31 36
6. M. Hellgren Hemostasis during normal pregnancy and puerperium Semin Thromb Hemost 29 2003 125 130
7. M. Hoke, P.A. Kyrle, and K. Philipp Prospective evaluation of coagulation activation in pregnant women receiving low-molecular weight heparin Thromb Haemost 91 2004 935 940
8. F. Dati, G. Hafner, and H. Erbes ProC Global: the first functional screening assay for the complete protein C pathway Clin Chem 43 1997 1719 1723
9. S. Eichinger, G. Hron, and M. Hirschl Prediction of recurrent venous thromboembolism by measuring ProC Global Thromb Haemost 98 2007 1232 1236
10. G. Hron, M. Kollars, B.R. Binder, S. Eichinger, and P.A. Kyrle Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation JAMA 296 2006 397 402
11. S. Eichinger, G. Hron, M. Kollars, and P.A. Kyrle Prediction of recurrent venous thromboembolism by endogenous thrombin potential and D-dimer Clin Chem 54 2008 2042 2048
12. A. Tripodi, I. Martinelli, V. Chantarangkul, T. Battaglioli, M. Clerici, and P.M. Mannucci The endogenous thrombin potential and the risk of venous thromboembolism Thromb Res 121 2007 353 359
13. A. Tripodi, C. Legnani, V. Chantarangkul, B. Cosmi, G. Palareti, and P.M. Mannucci High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism J Thromb Haemost 6 2008 1327 1333
14. M. Besser, C. Baglin, R. Luddington, A. van Hylckama Vlieg, and T. Baglin High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study J Thromb Haemost 6 2008 1720 1725
15. P.L. Lutsey, A.R. Folsom, S.R. Heckbert, and M. Cushman Peak thrombin generation and subsequent venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE) study J Thromb Haemost 7 2009 1639 1648
16. A. Rosenkranz, M. Hiden, and B. Leschnik Calibrated automated thrombin generation in normal uncomplicated pregnancy Thromb Haemost 99 2008 331 337
17. P. Toulon, W.M. Halbmeyer, and G. Hafner Screening for abnormalities in the protein C anticoagulant pathway using the ProC Global assay: results of a European multicenter evaluation Blood Coagul Fibrinolysis 11 2000 447 454
18. G. Sarig, I. Aberbach, L. Schliamser, Z. Blumenfeld, and B. Brenner Evaluation of ProCGlobal assay in women with a history of venous thromboembolism on hormonal therapy Thromb Haemost 96 2006 578 583
19. S. Wielders, M. Mukherjee, and J. Michiels The routine determination of the endogenous thrombin potential, first results in different forms of hyper- and hypocoagulability Thromb Haemost 7 1997 629 636